Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.

Robin L JonesRobert G MakiShreyaskumar R PatelGeorge WangTracy A McGowanWaleed S ShalabyRoland E KnoblauchMargaret von MehrenGeorge D Demetri
Published in: Cancer (2019)
Although the majority of patients who were randomized to trabectedin received outpatient therapy, the outcomes of the current study suggested equivalent safety and efficacy in either setting.